← Back to Analyst Consensus 
NGNE Buy
Neurogene Inc.
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 23, 2026 (28 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 8, 2026 | JP Morgan | initiate | — → Overweight | — | 54% |
| Aug 12, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Aug 12, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Aug 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 6, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Feb 27, 2026 | Canaccord Genuity | initiate | — → Buy | $200 | 48% |
| Jan 26, 2026 | LifeSci Capital | initiate | — → Outperform | $50 | 57% |
| Jan 13, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $70 | 44% |
| Nov 13, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $70 | 44% |
| Oct 31, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $65 | 44% |
| Oct 9, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $45 | 44% |
| Jun 17, 2025 | Craig-Hallum | initiate | — → Buy | $50 | 54% |
| Jun 12, 2025 | BMO Capital | maintain | Outperform → Outperform | $26 | 53% |
| May 20, 2025 | BMO Capital | maintain | Outperform → Outperform | $22 | 53% |
| May 16, 2025 | Baird | downgrade | Outperform → Neutral | $24 | 55% |
| May 13, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $45 | 44% |
| Apr 14, 2025 | BMO Capital | maintain | Outperform → Outperform | $16 | 53% |
| Mar 25, 2025 | Baird | maintain | Outperform → Outperform | $36 | 55% |
| Mar 25, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $50 | 44% |
| Nov 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| Nov 20, 2024 | BMO Capital | maintain | Outperform → Outperform | $45 | 53% |
| Nov 19, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| Nov 12, 2024 | Stifel | maintain | Buy → Buy | $60 | 53% |
| Nov 12, 2024 | BMO Capital | maintain | Outperform → Outperform | $60 | 53% |
| Nov 12, 2024 | Leerink Partners | maintain | Outperform → Outperform | $72 | 51% |
| Nov 12, 2024 | Baird | maintain | Outperform → Outperform | $72 | 55% |
| Nov 12, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $55 | 44% |
| Aug 12, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $49 | 44% |
| Jun 27, 2024 | BMO Capital | initiate | — → Outperform | $65 | 53% |
| Jun 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $51 | 44% |
| Jun 11, 2024 | Baird | initiate | — → Outperform | $54 | 55% |
| Jun 4, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $51 | 44% |
| May 13, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $51 | 44% |
| May 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| May 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| Apr 29, 2024 | Leerink Partners | initiate | — → Outperform | $46 | 51% |
| Mar 21, 2024 | William Blair | initiate | — → Outperform | $0 | 48% |
| Mar 19, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $55 | 44% |
| Mar 5, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $45 | 44% |
| Jan 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $45 | 44% |
| Jan 8, 2024 | HC Wainwright & Co. | initiate | — → Buy | $45 | 44% |
| Jan 5, 2024 | Stifel | initiate | — → Buy | $31 | 53% |
Price Target Trend
Mar 30, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days